Processa Acquisition Lands Immunology Drug That Could Rival a New Novartis Product
With the merger, Processa’s new lead asset is a Vidya Therapeutics immunology drug that provides pipeline-in-a-product potential addressing a goal ...
With the merger, Processa’s new lead asset is a Vidya Therapeutics immunology drug that provides pipeline-in-a-product potential addressing a goal ...
An Harm Monitoring System That Reaches Previous Its Personal JurisdictionA federal company that regulates garden mowers, cribs, and low makers ...
Argon AI has announced it secured $5.5 million in seed funding. Crosslink Capital and Wireframe Ventures co-led the round, with ...
Beauty & Health EditorHannah Frye is the Beauty & Health Editor at mindbodygreen. She has a B.S. in journalism and ...
Olio, a platform that links hospital teams with post-acute providers for care collaboration, scored $11 million in Series B funding ...
Resident insight and experience platform TSOLife scored $43 million in a Series B funding round led by PeakSpan Capital, bringing ...
Every beauty professional has their nonnegotiable steps. In our series, Like a Pro, we tap experts for the top three techniques ...
Highmark, an insurer in Pennsylvania, will now cover AppliedVR’s RelieVRx, a device for chronic low back pain, the companies announced ...
With the Well+Good SHOP, our editors put their years of know-how to work in order to pick products (from skin ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.